Associated Papers
RRAS and RRAS2 mutations are recurrent oncogenic drivers in lung cancer and are sensitive to the pan-RAS inhibitor RMC-6236.
Pfeil AJ et al.
Biorxiv : the Preprint Server for Biology, 2025
Clonal evolution in myelodysplastic syndromes.
da Silva-Coelho P et al.
Nature Communications, 2017
28429724 (PubMed )
Supplement: ncomms15099-s2.xlsx › UPN_all
Select a paper to view details